By Editor • August 20, 2026 • 1 min read
Excitement is palpable in the oncology community following the recent triumph of Merck and Moderna’s personalized mRNA cancer therapy for melanoma. This milestone, alongside Revolution Medicines' recent advancements with a KRAS-targeted drug, positions 2026 as a landmark year in cancer treatment history.
Source: www.statnews.com
By Editor • August 20, 2026 • 1 min read
Capricor Therapeutics' efforts to prevent FDA rejection of its Duchenne muscular dystrophy treatment appear futile, requiring a new clinical trial for approval.
Read moreBy Editor • August 20, 2026 • 1 min read
Patients in Rotherham are frustrated as an AI receptionist struggles to understand local accents, leading to communication issues at GP practices.
Read moreBy Editor • August 20, 2026 • 3 min read
Strikes by healthcare workers across the U.S. highlight growing violence and staffing shortages, prompting calls for better safety measures and support.
Read more
